Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Efficacy

Weight Loss Results

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

Lower cash prices with broad distribution aim to reach patients who avoided injections.

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity